Press Release
CoinBene launches contract insurance, allowing users to make a solid profit
CoinBene has been operating smoothly for nearly 4 years since its establishment in August 2017. Since the currency circle is updated quickly, CoinBene’s ability to run for three years is a proof of its strength.
CoinBene has obtained MSB financial license in the United States and MAS financial license in Singapore, with more than 100,000 daily users and daily transaction volume reaching USD 3 billion. In terms of ranking, CoinBene has become one of the first-tier exchanges.
According to relevant data, there are over 5 million registered users on CoinBene platform at present. The number of daily active users exceeds 100,000; The peak daily activity of the contract exceeds 15,000. The daily transaction volume exceeds 3 billion USDT. The peak value of contract transactions exceeded USDT 2 billion.
For the exchange, the larger the number of users, the more likely it is to have security problems. Under the background of frequent crash down and hacking in major exchanges, CoinBene has been running smoothly, and there has never been a safety accident.
Moreover, in order to better protect users’ assets, CoinBene has successively introduced payment mechanism and contract insurance. There is any platform safety accident, crash down, etc. on CoinBene platform. The platform will compensate in full. After users purchase contract insurance, liquidation can get claims.
CoinBene with double insurance mechanism is very reliable for users, especially inexperienced users.
CoinBene contract trading is growing rapidly after being launched. The number of daily active users of the contract has increased 202% year-on-year, and nearly 13,000 new users were registered in November. To address the security issues of the contract, CoinBene recently launched a number of measures, firstly, it launched the “guarantee to pay compensations” mechanism, and then on August 10, CoinBene launched the “contract insurance” function. The successive security initiatives are intended to give users multiple layers of protection for their positions, allowing all users to trade with peace of mind at CoinBene, regardless of the market’s ups and downs.
Double compensations, no fear of fluctuations
The contract market fluctuates frequently. On March 12, BTC plummeted from $7,000 to $3,800, and that night, long position liquidation was more than $5 billion. According to the data, on March 16, the contract market liquidation totaled $480 million, long position liquidation $303 million, short position liquidation $177 million.
CoinBene has been focusing on product security research and development since 2017, with 5 stars in Anchain and Bitforest professional penetration test reports. In the “March 12” incident, CoinBene did not crash down at all, avoiding unnecessary losses for users.
Based on the confidence in its own technology and responsibility to users, CoinBene has launched guarantee to pay compensations for all platform incidents during the trading process.
In addition to protecting users’ assets from the technical perspective of the platform, CoinBene has launched the “contract insurance” function in order to reduce the losses caused by users’ liquidation.
CoinBene’s contract insurance adopts the “double compensation” mechanism, and once liquidation occurs, it will be reviewed within 24 hours. After passing the review, the compensation will be paid on the next day.
The k line is unpredictable, no matter if people are masters or novices, there are always times when they can’t see the market or judge the trend, after purchasing the contract insurance, no matter how unpredictable the market is, it can protect positions from losses.
CoinBene intends to enhance the security of contracts through “guarantee to pay compensations” and “contract insurance”. No matter how the market fluctuates, users can open positions at any time in CoinBene without fear of fluctuations, security is guaranteed and liquidation is paid.
Easy to operate, stable profit
CoinBene’s contract insurance uses the “double compensation” mechanism, users only need to open a position at the same time to buy insurance, in case of market fluctuation liquidation, the platform will double the compensation. Users can get both the principal and the money purchased insurance, equivalent to capital preservation, to ensure that the steady income is not lost.
That is, if the insurance ratio purchased 100%, after the liquidation, a loss of $10. Then the user can get a $20 compensation, minus the $10 for buying insurance, the user gets back exactly $10 as principal.
CoinBene, established in 2017, has accumulated strong strength through three years of operation, and has set up a “10 million insurance fund” to ensure that all compensations are completed on time. The insurance fund exists independently of CoinBene and operates under the same logic as the traditional insurance industry, with the fund only used to pay out platform claims.
CoinBene has obtained MAS financial payment license in Singapore and MSB financial license in the U.S. Based on the global ecological layout, it has set up sub-stations in 9 countries around the world.
After CoinBene launched the contract, the data continued to grow – the average daily active trading users of the contract grew 200%, and the trading volume grew 47%. nearly 13,000 new registered users were added in November, and the contract trading volume exceeded 257.1 billion.
With the growth of users, user demand is gradually increasing. CoinBene has launched a number of contract support functions: a simple version of the contract for novice users, a one-click order follow-up for contract newcomers to increase their profits, and the recent security mechanism – guarantee to pay compensations mechanism and contract insurance ……
All features, mechanisms, are designed to enhance the user’s trading experience, regardless of the ups and downs of the market, so that all users can trade with peace of mind in CoinBene, which is the original aspiration of CoinBene, which has been available for three years.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
LF Labs is extending its Web3 influence with a global PoS rollout and 20 new exchange listings on July 30, driving LF Coin toward $1 by that milestone.
Strong Expansion Bolsters Market Confidence
Dubai, UAE, 6th July 2025, ZEX PR WIRE, LF Labs (LF Coin) is gearing up for a major milestone on July 30, when it will secure listings on 20 additional exchanges. This move underscores LF Labs’ commitment to building a comprehensive Web3 infrastructure, and it arrives just as LF Coin gains traction in both utility and market sentiment.
Market Momentum and Technical Outlook
On July 1, LF Coin rallied 29% in one day to close at 0.0007793 USDT, accompanied by a surge in trading volume and a shift toward bullish technical indicators. According to the 4-Hour analysis chart, LF/USDT has broken out above its rising EMA, with a bullish MACD crossover and RSI popping above 70, signaling fresh upside momentum. Expect a run toward 0.00085 USDT—and potentially 0.0010—if this strength continues.
Source : TradingView
Real-World Utility Fuels Demand
LF Labs is preparing to deploy blockchain-powered PoS machines that facilitate instant crypto-to-fiat conversions for merchants worldwide. Early pre-bookings suggest strong merchant interest, and each transaction processed through these devices is designed to increase demand for LF Coin as we approach the July 30 listings. In tandem with its PoS terminals, LF Labs also offers the LF Wallet, a secure, user-friendly app that lets merchants and consumers store, send and receive LF Coin seamlessly—and automatically routes funds through the PoS devices for instant crypto-to-fiat settlements.
Integrated Ecosystem Addresses Industry Fragmentation
By offering a full stack of solutions—from project acceleration and market-making to seamless payment infrastructure—LF Labs aims to bridge gaps across the crypto industry. As highlighted in its recent announcement on X (formerly Twitter), LF Labs Token, this integrated approach provides tangible utility beyond what many speculative tokens can claim.
Technical Milestones Point to $1 Target
Analysts are closely watching the 0.000740 USDT resistance level. A decisive break and sustained hold above this threshold could open the door to the psychological 0.001000 USDT mark, setting the stage for the $1 target by the July 30 exchange listings. Support near 0.000580 USDT remains firm, offering a solid base for further gains.
Anniversary Listings to Enhance Liquidity
To mark its fourth anniversary on July 30, LF Labs is orchestrating simultaneous listings across 20 exchanges. This expanded market access is expected to deepen liquidity, broaden investor participation, and reinforce the upward trajectory of LF Coin.
Sustainable Growth Through Low Frequency Accelerator
Beyond infrastructure, LF Labs supports emerging blockchain startups via its Low Frequency Accelerator, providing capital, liquidity, and technical expertise. This end-to-end support not only strengthens the broader ecosystem but also channels additional demand back into LF Coin.
Conclusion
With robust technical signals, real-world utility, and a strategic expansion plan—including global PoS deployment and 20 exchange listings on July 30—LF Labs is primed for a potential surge toward the $1 mark by that very milestone.
Frequently Asked Questions
- What is LF Coin?
LF Coin is LF Labs’ native utility token, powering transactions within its PoS ecosystem, rewarding network participants, and enabling staking for governance. - How can I buy LF Coin?
You can purchase it using USDT or other major trading pairs on any supported platform such as Gate.io, HTX, and MEXC. - What are LF Labs PoS machines?
These are blockchain-powered point-of-sale terminals that convert cryptocurrencies into local fiat in real time, designed for merchants seeking seamless Web3 payment solutions. - How do I pre-book a PoS machine?
You can pre-book through the LF Labs website now. - Where and when will LF Coin be listed?
LF Coin listings go live simultaneously on July 30 across 20 major centralized exchanges. Check LF Labs’ official channels for the complete exchange roster and trading pairs.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
British Virgin Islands, BVI, 6th July 2025, ZEX PR WIRE, Enterprise-level adoption of AI agents has reached a critical turning point, yet the majority of implementations fail at the execution layer. While current AI agents excel at understanding intent, they consistently struggle to deliver reliable, auditable actions across fragmented multi-chain ecosystems. FlowAgent, developed by Tearline, represents a fundamental breakthrough in bridging this execution gap through transparent, verifiable automation.
It is more than a Web3 automation layer. It’s a transparent, modular, programmable coordination engine — turning high-level intent with natural languages into structured, verifiable action across decentralised networks. And more importantly, it lays the groundwork for a new class of software-native agents: collaborative, auditable, and ready for distributed production.
Execution Infrastructure for the Intent Economy
FlowAgent rethinks how agent systems interface with real-world protocols. Built around a state-visible execution pipeline, it translates user intent into stepwise, auditable workflows. Each operation is encoded as a directed acyclic graph (DAG), enabling developers and users alike to observe and verify execution logic in real time.
Modular Workflows, Composable Behaviour
-
Composable Intelligence: Developers can chain together on-chain operations as structured, state-aware modules.
-
Dynamic Graph Scheduling: Workflows can adapt in-flight based on context, failure state, or cross-agent input.
-
Protocol Extensibility: New chains or components can be integrated without re-architecting the agent runtime.
From Isolated Prompts to Agent Networks
-
Distributed task planning
-
Contextual state and memory sharing
-
Scoped authority and permission-aware delegation
Engineering Breakthrough: Orchestration at Scale
From Web3 Automation to System-Level Intelligence
About Tearline
- Chatpilot – An intent-centric AI chatbot deployed on BNB Chain, Sui and TON, streamlining user onboarding and on-chain actions via natural language.
- GhostDriver – An execution-focused agent that automates web-based tasks across both Web2 and Web3 environments.
- FlowAgent – A newly launched task orchestrator enabling multi-agent coordination and smart contract execution.
Website: tearline.io
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Dr. Christopher E. Touloukian Reaches 2,367 Citations on ResearchGate for Pioneering Cancer Immunotherapy Research
Massachusetts, US, 6th July 2025, ZEX PR WIRE, Dr. Christopher E. Touloukian, a board-certified surgical oncologist and general surgeon, has officially surpassed 2,367 citations on ResearchGate, a leading platform for academic publishing and peer collaboration. This milestone reflects Dr. Touloukian’s enduring contributions to the field of cancer immunotherapy and underscores the global influence of his two-decade-long commitment to improving cancer treatment through rigorous research and surgical innovation.
A Career Built on Translational Excellence
Dr. Touloukian’s path in medicine began with his graduation from Columbia University College of Physicians and Surgeons, one of the most prestigious medical schools in the country. He then completed rigorous general surgery training at Yale University and Duke University, where he honed his technical skill and deepened his understanding of complex oncologic conditions.
Following his residency, Dr. Touloukian earned coveted fellowship positions in Surgical Oncology and Immunotherapy at the National Cancer Institute (NCI) and the National Institutes of Health (NIH). It was there that his interest in tumor immunology took firm root. Immersed in one of the world’s most advanced cancer research environments, he began developing the scientific foundation for what would become a lifelong mission: to integrate immune-based strategies into clinical cancer care.
A Milestone That Reflects Global Impact
The 2,367 citations on ResearchGate represent more than numbers. They illustrate thebreadth of Dr. Touloukian’s impact in scientific literature and the trust placed in his work by researchers, clinicians, and academic institutions worldwide. His research spans a range of high-stakes topics within oncology, including tumor-specific T-cell activation, immune checkpoint modulation, antigen presentation, interferon signaling, and the tumor microenvironment.
His most cited publications explore how tumors evade immune surveillance and how novel immunotherapies can restore or enhance immune responses. Among them are key contributions to our understanding of how CD8+ and CD4+ T cells coordinate to target malignancies, and how certain tumor antigens might be used in vaccine development. His work has appeared in respected journals including Cancer Research, The Journal of Immunology, and Nature Medicine.
Surgical Precision Meets Research Rigor
What distinguishes Dr. Touloukian is his ability to apply groundbreaking scientific insight to real-world clinical practice. As a surgical oncologist, he regularly manages complex cases involving gastrointestinal cancers, soft tissue sarcomas, and cutaneous malignancies. He treats patients across multiple states, holding active medical licenses in New York, Massachusetts, and Florida.
Whether he is in the operating room or consulting with colleagues on a multidisciplinary cancer board, Dr. Touloukian brings a research-informed approach to decision-making. He believes that every cancer case presents not only a surgical challenge but also an opportunity to apply or test the latest evidence-based therapies. This perspective has helped improve outcomes and has positioned him as a trusted authority in high-acuity medical settings.
Academic Leadership and Mentorship
Dr. Touloukian’s commitment to education is another key pillar of his career. He has served as a faculty member at Indiana University School of Medicine in the Department of Microbiology and Immunology. There, he mentored both medical students and researchers, helping guide the next generation of clinician-scientists.
His teachings emphasize the importance of questioning assumptions, applying rigorous methodology, and never losing sight of the patient behind the protocol. His dual role as a practicing surgeon and active researcher enables him to offer students a comprehensive view of how science and medicine can work together in service of better care.
Recognition from Peers and Foundations
In 2010, Dr. Touloukian was named a V Scholar by the V Foundation for Cancer Research. This competitive award recognizes promising physician-scientists conducting innovative cancer research at a national level. The award served as both validation and fuel for Dr. Touloukian’s continued investigations into immune modulation, antigen engineering, and therapeutic resistance mechanisms.
In the years since receiving the V Scholar award, Dr. Touloukian has published over 25 scientific papers and contributed to numerous collaborative projects. His work has not only earned citations but also inspired new research directions and clinical trials. Several of his
studies have informed current immunotherapy protocols and biomarker strategies now used in hospitals and research centers across the United States.
The Power of Peer Collaboration
The visibility and engagement Dr. Touloukian has achieved on ResearchGate also speak to his collaborative spirit. The platform has allowed him to share findings, respond to inquiries, and participate in global scientific dialogue. His profile is a living archive of progress in tumor immunology, where researchers can track both published works and the evolving ideas that shape them.
By making his work accessible, Dr. Touloukian invites others to build on his research, test new hypotheses, and refine therapeutic strategies. This openness accelerates discovery and helps ensure that findings move from the page to the patient as efficiently as possible.
Future Directions: From Lab to Life
Despite this significant citation milestone, Dr. Touloukian remains focused on what liesahead. He is currently involved in several projects exploring the next generation of immunotherapeutic approaches, including T-cell engineering, antigen-specific vaccine development, and the role of regulatory T cells in immune suppression.
He also continues to study how the tumor microenvironment influences treatment resistance, with the goal of finding new ways to disrupt the protective barriers that tumors build against the immune system. His future research will likely continue to bridge lab science and patient care, with an eye toward therapies that are not only effective but also tailored to the biology of each individual’s disease.
More Than Metrics: A Career Guided by Purpose
While the citation count offers a tangible measure of scientific impact, it does not capture the full story of Dr. Touloukian’s career. Behind every publication is a deep sense of purpose, a desire to make cancer less formidable, and a belief in the potential of science to change lives.
Colleagues describe him as both brilliant and approachable, someone who brings the same energy to a late-night research meeting as he does to a difficult surgical case. Patients see in him not just a doctor, but an advocate who listens, informs, and fights alongside them.
His journey is not only about discovery, but about translation — taking complex ideas and turning them into actionable treatments. This approach continues to resonate throughout his academic work, clinical practice, and mentorship.
A Legacy Still in Motion
As he surpasses 2,367 citations on ResearchGate, Dr. Christopher E. Touloukian’s influence is as dynamic as the field he helps shape. His work stands at the frontier of medicine, where science meets humanity, and where data becomes healing. For those who know him, this milestone is no surprise — it is simply another step in a career defined by excellence, empathy, and an unwavering commitment to making cancer care smarter and more hopeful.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
LF Labs’ July 30 Listing Blitz: The Catalyst That Could Propel LF Coin to $1
Dr. Christopher E. Touloukian Reaches 2,367 Citations on ResearchGate for Pioneering Cancer Immunotherapy Research
Introducing Tearline’s FlowAgent: A Modular AI Agent Bridging the Execution Trust Gap
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Microsoft License Enables Organizations to Navigate the Evolving Digital Landscape Through Customized Microsoft Solutions
-
Press Release1 week ago
AIDAv2 The Future of Investment in the Age of AI and How Its Shaping a New Financial Paradigm
-
Press Release1 day ago
Pichai Applauds Record-Breaking Success of THAIFEX – ANUGA ASIA 2025 Over 142,000 Visitors and Trade Value Surpassing 135 Billion Baht
-
Press Release1 week ago
Abrdn Grubu Leads the Future of Finance with AI and Technology Integration
-
Press Release1 week ago
Cloud mining giant FansHash Launches free and efficient cloud mining applications to easily improve mining efficiency and achieve simple operation
-
Press Release1 week ago
Nanolite Foundation Pioneering the Future of Technology Investment and Social Impact
-
Press Release6 days ago
Nectaren Embraces Sentimental Shopping Trends with Symbolic Story-Driven Products
-
Press Release6 days ago
DragonPro Unveils First Fully Autonomous AI Crypto Trading Platform
-
Press Release4 days ago
Atelier Home Sets a New Standard for Luxury Home Decor